Cargando…

Novel Insights into the Molecular Mechanisms of Atherosclerosis

Atherosclerosis is one of the most fatal diseases in the world. The associated thickening of the arterial wall and its background and consequences make it a very composite disease entity with many mechanisms that lead to its creation. It is an active process, and scientists from various branches are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojtasińska, Armanda, Frąk, Weronika, Lisińska, Wiktoria, Sapeda, Natalia, Młynarska, Ewelina, Rysz, Jacek, Franczyk, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487483/ https://www.ncbi.nlm.nih.gov/pubmed/37686238 http://dx.doi.org/10.3390/ijms241713434

Ejemplares similares

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
por: Dąbek, Bartłomiej, et al.
Publicado: (2023)

New Insights into Molecular Mechanisms of Chronic Kidney Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Molecular Interactions of Arterial Hypertension in Its Target Organs
por: Kućmierz, Joanna, et al.
Publicado: (2021)

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
por: Frąk, Weronika, et al.
Publicado: (2023)

Cellular Mechanisms of Coronary Artery Spasm
por: Franczyk, Beata, et al.
Publicado: (2022)

New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
por: Wronka, Magdalena, et al.
Publicado: (2023)

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
por: Fularski, Piotr, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
por: Baran, Wiktoria, et al.
Publicado: (2021)

Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure
por: Tokarek, Julita, et al.
Publicado: (2023)

Advances in Treatment of Dyslipidemia
por: Dybiec, Jill, et al.
Publicado: (2023)

Acute Kidney Injury in COVID-19
por: Głowacka, Marta, et al.
Publicado: (2021)

Arterial Hypertension—Oxidative Stress and Inflammation
por: Krzemińska, Julia, et al.
Publicado: (2022)

What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related Diseases
por: Tokarek, Julita, et al.
Publicado: (2021)

Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19
por: Młynarska, Ewelina, et al.
Publicado: (2022)

The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
por: Wronka, Magdalena, et al.
Publicado: (2022)

Chronic Kidney Disease as a Comorbidity in Heart Failure
por: Szlagor, Magdalena, et al.
Publicado: (2023)

Structural and Functional Changes in Aging Kidneys
por: Dybiec, Jill, et al.
Publicado: (2022)

New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023)

New Insights into the Use of Empagliflozin—A Comprehensive Review
por: Forycka, Joanna, et al.
Publicado: (2022)

Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
por: Tokarek, Julita, et al.
Publicado: (2023)

Empagliflozin—A New Chance for Patients with Chronic Heart Failure
por: Kowalska, Klaudia, et al.
Publicado: (2021)

The Influence of SARS-CoV-2 Infection on Lipid Metabolism—The Potential Use of Lipid-Lowering Agents in COVID-19 Management
por: Kowalska, Klaudia, et al.
Publicado: (2022)

Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)

The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
por: Kowalska, Klaudia, et al.
Publicado: (2022)

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
por: Młynarska, Ewelina, et al.
Publicado: (2022)

Advances in the Pathogenesis and Treatment of Resistant Hypertension
por: Dybiec, Jill, et al.
Publicado: (2023)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
por: Rysz, Jacek, et al.
Publicado: (2017)

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease
por: Rysz, Jacek, et al.
Publicado: (2017)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients
por: Gluba-Brzozka, Anna, et al.
Publicado: (2019)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

Diabetes and Cardiovascular Risk in Renal Transplant Patients
por: Rysz, Jacek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ucoaikrqg23mvo71tfe043cvag